A randomized, controlled pilot study to evaluate the safety and efficacy of intravitreal fluocinolone acetonide (0.5mg and 2mg) implants in patients with clinically significant diabetic macular edema.
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2013
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
- 11 Jan 2008 New trial record.